serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| response to nutrient |
|
|
| blood coagulation |
|
|
| regulation of blood coagulation |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| obsolete extracellular space |
|
|
| extracellular matrix |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| protease binding |
|
|
| protease binding |
|
|
| serine-type endopeptidase inhibitor activity |
|
|
| serine-type endopeptidase inhibitor activity |
|
|
| serine-type endopeptidase inhibitor activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:3755 | antithrombin III deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026